Related Experiment Videos
Long-term visual results after laser photocoagulation for diabetic maculopathy
M Stefaniotou1, C Kalogeropoulos, K Psilas
1University Eye Clinic of Ioannina Medical School, Greece.
Summary
Modified grid laser photocoagulation effectively preserves or improves vision in diabetic maculopathy patients, especially when initiated early. This treatment offers benefits for early-stage disease but has less impact on advanced cases.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy Management
- Medical Laser Applications
Background:
- Diabetic maculopathy is a leading cause of vision loss in diabetic patients.
- Effective long-term management strategies for diabetic maculopathy are crucial.
- Laser photocoagulation is a common treatment modality.
Purpose of the Study:
- To evaluate the long-term visual outcomes of modified grid laser photocoagulation in diabetic maculopathy.
- To assess the efficacy of the procedure based on pre-treatment visual acuity.
- To determine the impact of treatment on the natural course of the disease.
Main Methods:
- A prospective study involving 104 eyes of 56 diabetic patients.
- Modified grid laser photocoagulation was performed following established protocols.
- Patients were categorized into three groups based on pre-treatment visual acuity (A: <0.2, B: 0.3-0.6, C: >0.7).
- Follow-up ranged from 12 months to 2.5 years.
Main Results:
- At 1 year, visual acuity improvement/preservation rates were 79.4% (Group A), 38.9% (Group B), and 88.2% (Group C).
- At 2.5 years, rates were 85.7% (Group A), 27.3% (Group B), and 75% (Group C).
- Significantly better outcomes were observed in Groups A and C compared to Group B.
Conclusions:
- Modified grid laser photocoagulation is effective for 'early treated' eyes (visual acuity ≥0.7).
- The procedure can improve or preserve vision in patients with early to moderate diabetic maculopathy.
- It does not significantly alter the natural disease progression in eyes with poorer initial visual acuity.